Sadif Investment Analytics Downgrades GSK to Hold, Cuts PT

Published on 2025-06-13 at 07:35

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about GSK plc

FTSE 100 retreats from record high as tariff worries resurface	07-15	RE
European Equities Close Lower in Tuesday Trading; EU Targets Industrial Goods in Tariff Row	07-15	MT
GSK : Receives a Sell rating from JP Morgan	07-15	ZD
FDA staff flags eye safety risks for GSK's blood cancer drug	07-15	RE
GSK Shares Rise Ahead of FDA Decision on Blood Cancer Drug	07-15	MT
FDA staff raises eye damage concerns for GSK's blood cancer drug	07-15	RE
GSK : Deutsche Bank reiterates its Neutral rating	07-15	ZD
European Equities Close Mixed in Monday Trading; EU Signals Readiness to Retaliate Against US Tariffs	07-14	MT
GSK-backed ViiV Healthcare Adds Injectable Cabotegravir to HIV Medicines Patent Pool License Deal	07-14	MT
GSK Viiv Extends Cabotegravir Licensing Deal to Include HIV Treatment	07-14	MT
GSK seeks FDA nod for expanded use of RSV vaccine in adults	07-14	RE
Global markets live: Tesla, Gilead, Kenvue, Amazon, Bayer…	07-14
ViiV expands licence to allow generic HIV treatment production for low-income countries	07-14	RE
GSK Seeks FDA Approval to Expand RSV Vaccine Use to At-Risk Adults Aged 18-49	07-14	MT
GSK: seeks FDA approval to expand Arexvy indication	07-14
GSK seeks FDA green light for expanded use of RSV vaccine Arexvy	07-14	AN
DCC sells unit; South32 warns of Mozal impairment	07-14	AN
US FDA Accepts GSK's Application to Expand Indication for RSV Vaccine	07-14	MT
GSK submits Arexvy for adults 18-49 air to FDA	07-14	RE
GSK seeks FDA nod for expanded use of RSV vaccine in adults	07-14	RE
Sector Update: Health Care Stocks Slide Friday Afternoon	07-11	MT
FTSE 100 eases from record levels amid soft GDP	07-11	AN
European Equities Traded in the US as American Depositary Receipts Drop Sharply in Friday Trading	07-11	MT
FDA May Fast Track Drug Reviews for Lower US Prices	07-11	MT
FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports	07-11	MT